Veracyte, Inc. ( VCYT) - Stock Earnings
VCYT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 5, 2026, midnight | — / — | — | — / — | — |
VCYT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 19.1 million USD | 131.9 million USD |
| 2025Q4 | 41.1 million USD | 140.6 million USD |
| 2026Q1 | 28.7 million USD | 139.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
VCYT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -74.4 million USD | 361.1 million USD |
| 2024 | 24.1 million USD | 445.8 million USD |
| 2025 | 66.4 million USD | 517.1 million USD |
| 2026 Est. | — | — |
VCYT
Price: $59.53
Earnings Per Share: 1.08 USD
P/E Ratio: 36.76
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 321710
Ebitda: -5.2 millionMarket Capitalization: 4.6 billion